Cytrellis Biosystems is launching the next generation of its ellacor system with Micro-Coring technology.

The ellacor system with Micro-Coring technology is the first and only minimally invasive, in-office procedure to remove sagging skin, treat wrinkles, and rejuvenate skin. Cleared by the U.S. Food and Drug Administration (FDA) in 2021, this system works on a micro-scale to target moderate and severe wrinkles in the mid and lower face.  Micro-Coring is a proprietary technology that removes skin surface area and stimulates the body’s natural healing process. It uses hollow needles to remove micro-cores of dermal and epidermal tissue without surgery, thermal energy or evidence of scarring.

The updated ellacor (ellacor 2.0) offers user-friendly technology and new protocols for enhanced patient and provider satisfaction